Research and development
- Categories:Research and development
- Time of issue:2021-05-28 15:59:08
The company has a provincial-level research institute and a provincial-level academician workstation, and consists of an API R&D center, a preparation R&D center, an analysis center and a pilot plant. The research and development content covers multiple directions such as chemical drugs, biological drugs, and preparations. The Provincial Academician Workstation is dedicated to the research of new biological drugs and new pharmaceutical technologies. The institute currently has doctoral, master, and undergraduate students. It has extensive and in-depth cooperation with well-known domestic universities and scientific research institutions such as Shanghai Medical Engineering Institute, Tsinghua University, Peking University, Zhejiang University, University of Science and Technology of China, Nankai University, Zhejiang University of Technology, and Sichuan Anti-Virus. The annual R&D investment accounts for more than 3% of the company's total sales. A complete R&D innovation system and assessment and reward system have been established. In recent years, the company has achieved more than 20 research and development projects each year, and has achieved outstanding results in product development and technological innovation.
|Zhejiang Academician Expert Workstation||Joint Research Center of Shanghai Pharmaceutical Industry Research Institute||Tsinghua University Graduate Employment Practice Base|